<DOC>
	<DOCNO>NCT00004357</DOCNO>
	<brief_summary>Juvenile dermatomyositis ( JDM ) connective tissue disease cause skin rash weak muscle child . The purpose study measure absorption oral prednisolone intravenous ( IV ) methylprednisolone determine level disease activity indicator blood . These level compare see pattern specific active less active JDM .</brief_summary>
	<brief_title>Absorption Corticosteroids Children With Juvenile Dermatomyositis</brief_title>
	<detailed_description>JDM connective tissue disease characterize inflammation muscle skin . Corticosteroids , prednisolone methylprednisolone , administer help control symptoms disease , absorption pattern medication oral IV form unknown . This study assess absorption oral prednisolone IV methylprednisolone , measure level two disease activity indicator ( von Willebrand factor neopterin ) , correlate value child JDM . Patients participate study twice within period year , patient 's disease active , 6 12 month later disease less active . Each two study period last two night two day . Patients admit hospital first night , small IV port insert patient 's arm first morning allow multiple blood draw without additional needle stick . Patients receive oral prednisolone first morning IV methylprednisolone second morning . Baseline blood draw perform prior administration drug , 13 additional draw 6 hour period follow drug administration . Following final blood draw second day , IV port remove patient 's arm patient discharge hospital . Blood drawn patient assessed absorption drug level von Willebrand factor neopterin . Patients undergo sequence event sometime 6 12 month first hospitalization , vasculitis judge less active .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Dermatomyositis</mesh_term>
	<mesh_term>Connective Tissue Diseases</mesh_term>
	<mesh_term>Vasculitis , Leukocytoclastic , Cutaneous</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Juvenile dermatomyositis evidence active vasculitis Elevated von Willebrand factor antigen prior study entry Elevated neopterin level prior study entry Severe renal involvement Critically ill clinically unstable Diseases dermatomyositis vasculitis</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Respiratory Disease</keyword>
	<keyword>Rare Diseases</keyword>
	<keyword>Vasculitis</keyword>
</DOC>